|
|
40
|
01243
|
OPTOMYCIN 0.5% EYE DR (ASL/PHA) CHLORAMPHENIC
|
CHLORAMPHENICOL
|
OPTOMYCIN
|
10ML
|
C
|
4.08
|
4.08
|
EYE DROP
|
0
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
41
|
03248
|
GENOPTIC 0.3% EYE DR (ASL/PHA) GENTAMICIN
|
GENTAMICIN
|
GENOPTIC
|
5ML
|
BQ
|
7.34
|
7.3395
|
EYE DR
|
1
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
520404
|
EENT ANTIBACTERIALS
|
|
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
40
|
03248
|
GENOPTIC 0.3% EYE DR (ASL/PHA) GENTAMICIN
|
GENTAMICIN
|
GENOPTIC
|
5ML
|
BQ
|
4.08
|
4.08
|
EYE DROP
|
1
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
40
|
0531V
|
IMURAN 50MG TAB (ASG/STO) AZATHIOPRINE
|
AZATHIOPRINE
|
IMURAN
|
100'S
|
C
|
174.27
|
1.74
|
TABLET
|
0
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
40
|
05752
|
ENDOXAN 1G INJ (ASM/COL) CYCLOPHOSPHAMIDE
|
CYCLOPHOSPHAMIDE
|
ENDOXAN
|
1G VIAL
|
BQ
|
38.06
|
38.06
|
INJECTION
|
0
|
VIAL
|
ASM
|
ASTA MEDICA AG
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
41
|
0621C
|
PURINETHOL 50MG TAB (ASG/STO) MERCAPTOPURINE
|
MERCAPTOPURINE
|
PURINETHOL
|
25'S
|
C
|
107.51
|
4.3004
|
TAB
|
60
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
|
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
40
|
0621C
|
PURINETHOL 50MG TAB (ASG/STO) MERCAPTOPURINE
|
MERCAPTOPURINE
|
PURINETHOL
|
25'S
|
A
|
104.38
|
4.18
|
TABLET
|
60
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
41
|
07141
|
ATROPINE SULPHATE 1% EYE DR (ASL/PHA)
|
ATROPINE SULPHATE
|
ATROPINE SULPHATE
|
10ML
|
A
|
13.29
|
13.2926
|
EYE DR
|
20
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5224
|
EENT MYDRIATICS
|
|
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
40
|
07141
|
ATROPINE SULPHATE 1% EYE DR (ASL/PHA)
|
ATROPINE SULPHATE
|
ATROPINE SULPHATE
|
10ML
|
A
|
11.66
|
11.66
|
EYE DROP
|
1
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5224
|
EENT MYDRIATICS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
41
|
1171V
|
ALDOMET 250MG TAB (ASG/STO) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
11.63
|
0.3878
|
TAB
|
180
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
|
|
|
ORAL
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
40
|
1171V
|
ALDOMET 250MG TAB (ASG/STO) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
5.44
|
0.18
|
TABLET
|
180
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
41
|
1172K
|
ALDOMET 500MG TAB (ASG/STO) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
19.03
|
0.6343
|
TAB
|
180
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
|
|
|
ORAL
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
40
|
1172K
|
ALDOMET 500MG TAB (ASG/STO) METHYLDOPA
|
METHYLDOPA
|
ALDOMET
|
30'S
|
A
|
8.83
|
0.29
|
TABLET
|
180
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
240816
|
CENTRAL ALPHA ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
41
|
22411
|
FRAMOPTIC D 0.05%|0.5%|0.005% EYE/EAR DR (ASL/PHA) DEXAMETHASONE|FRAMYCETIN|GRAM More ...
|
DEXAMETHASONE|FRAMYCETIN|GRAMICIDIN
|
FRAMOPTIC D
|
10ML
|
C
|
12.72
|
12.7218
|
EYE/EAR DR
|
1
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
40
|
22411
|
FRAMOPTIC D EYE DR (ASL/PHA) DEX/FRAMY/GRAMI
|
DEXAMETHASONE|FRAMYCETIN|GRAMICIDIN
|
FRAMOPTIC D
|
10ML
|
C
|
8.07
|
8.07
|
EYE DROP
|
0
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
41
|
2411B
|
HYPROMELLOSE 0.3% EYE DR (ASL/PHA)
|
HYPROMELLOSE
|
HYPROMELLOSE
|
10ML
|
A
|
7.64
|
7.6385
|
EYE DR
|
1
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5292
|
EENT DRUGS MISCELLANEOPUS
|
|
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
40
|
2411B
|
HYPROMELLOSE 0.3% EYE DR (ASL/PHA)
|
HYPROMELLOSE
|
HYPROMELLOSE
|
10ML
|
A
|
3.75
|
3.75
|
EYE DROP
|
1
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5292
|
EENT DRUGS MISCELLANEOPUS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
41
|
2791D
|
OVESTIN 1MG VAG CR (ASG/STO) ESTRIOL
|
ESTRIOL
|
OVESTIN
|
15G
|
A
|
42
|
41.9981
|
VAG CR
|
1
|
TUBE
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
681604
|
ESTROGENS
|
|
|
|
Vaginal
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
40
|
2791D
|
OVESTIN 1MG VAG CR (ASP/STO) ESTRIOL
|
ESTRIOL
|
OVESTIN
|
15G
|
A
|
41.59
|
41.59
|
VAGINAL CREA
|
1
|
TUBE
|
ASP
|
ASTRAPIN, PHARMA GMBH & CO. HG
|
STO
|
BRYDEN STOKES LTD
|
|
681604
|
ESTROGENS
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat A
|
Vaginal
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
2021-12-06
|
|
|
41
|
27921
|
OVESTIN 0.5MG OV (ASG/STO) ESTRIOL
|
ESTRIOL
|
OVESTIN
|
15'S
|
A
|
41.9981
|
41.9981
|
OV
|
1
|
PACK
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
681604
|
ESTROGENS
|
|
|
|
VAGINAL
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|